Eva Wessel Stratford
Overview
Explore the profile of Eva Wessel Stratford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanes R, Munthe E, Grad I, Han J, Karlsen I, McCormack E, et al.
Cells
. 2019 Feb;
8(2).
PMID: 30795553
FGFR inhibition has been proposed as treatment for dedifferentiated liposarcoma (DDLPS) with amplified , but we previously only demonstrated transient cytostatic effects when treating -amplified DDLPS cells with NVP-BGJ398. Effects...
2.
Amodeo V, A D, Betts J, Bartesaghi S, Zhang Y, Richard-Londt A, et al.
Cell Rep
. 2017 Jul;
20(2):411-426.
PMID: 28700942
Cell migration through the brain parenchyma underpins neurogenesis and glioblastoma (GBM) development. Since GBM cells and neuroblasts use the same migratory routes, mechanisms underlying migration during neurogenesis and brain cancer...
3.
Safavi S, Jarnum S, Vannas C, Udhane S, Jonasson E, Tesan Tomic T, et al.
Oncotarget
. 2015 Nov;
7(1):433-45.
PMID: 26595521
Myxoid sarcoma (MLS) is one of the most common types of malignant soft tissue tumors. MLS is characterized by the FUS-DDIT3 or EWSR1-DDIT3 fusion oncogenes that encode abnormal transcription factors....
4.
Stratford E, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S, et al.
Cancer Med
. 2014 Jan;
3(1):36-46.
PMID: 24403055
Wnt/β-catenin is a major regulator of stem cell self-renewal and differentiation and this signaling pathway is aberrantly activated in a several cancers, including osteosarcoma (OS). Attenuation of Wnt/β-catenin activity by...
5.
Skarn M, Baroy T, Stratford E, Myklebost O
PLoS One
. 2013 Nov;
8(11):e79231.
PMID: 24236112
The transcripts encoded by the microRNA mir-142 gene are highly active in hematopoietic cells, but expressed at low levels in many other cell types. Treatment with the demethylating agent 5-Aza-2'-deoxycytidine...
6.
Stratford E, Bostad M, Castro R, Skarpen E, Berg K, Hogset A, et al.
Biochim Biophys Acta
. 2013 May;
1830(8):4235-43.
PMID: 23643966
Background: The normal stem cell marker CD133 is also a putative marker of cancer stem cells (CSCs) in different types of cancers. Hence, a major challenge when targeting CD133-expressing CSCs...